My pleasure sir.

Plus the current Phase 1 clinical trial with Kevetrin alone is jointly with both Dana-Farber and Beth Israel Deaconess, both members of the Harvard Cancer Center.

So if this new research result leads to a Phase 2 Clinical Trial at Beth Israel, that will be the second Kevetrin trial hosted there.